GENETIC SUSCEPTIBILITY OF TRANSCRIPTION FACTOR 7-LIKE 2 GENE VARIANT AND RISK OF TYPE 2 DIABETES IN ASIAN INDIANS
Background: The variants of transcription factor 7-like 2 (TCF7L2) gene have been shown to be associated with type 2 diabetes mellitus (T2DM) and its related complications.
Objectives: We aimed to explore the possible association of rs7903146 (C/T) variant in TCF7L2 with the risk of T2DM in the North Indian population.
Methods: The present case–control study included a total of 638 human subjects (318 T2DM subjects and 320 healthy controls). Various anthropometric, biochemical, and genetic parameters were studies in all the subjects. Genotyping of TCF7L2 gene was carried out using allele-specific polymerase chain reaction method.
Results: The results of this study indicate significantly higher values of body mass index, waist circumference, waist-to-hip ratio, and body fat (%) in T2DM subjects than controls (p≤0.001). Dyslipidemia represented by higher levels of triglycerides and reduced values of high-density lipoprotein was more predominant in diabetic subjects compared to healthy subjects. The frequency of risk genotype (TT) frequency was significantly higher in T2DM subjects (16.4%) compared to controls (11.6%). The “T” allele was more dominant in diabetic subjects than controls. Logistic regression analysis of the data revealed a significant association of TT genotype with 2-fold (odds ratio with 95% of confidence interval; 2.09 [1.29–3.42] p=0.003) and CT genotype with 1.7-fold (1.73 [1.23–2.44] p=0.002) increased risk of developing T2DM.
Conclusions: The present study demonstrated a significant association of rs7903146 (C/T) variant in TCF7L2 with the augmented risk of T2DM in North Indian population.
2. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40-50.
3. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. International Diabetes Federation; 2017. Available from: https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/134:idf-diabetes-atlas-8th-edition.html.
4. Bhatti GK, Bhadada SK, Vijayvergiya R, Mastana SS, Bhatti JS. Metabolic syndrome and risk of major coronary events among the urban diabetic patients: North indian diabetes and cardiovascular disease study-NIDCVD-2. J Diabetes Complications 2016;30:72-8.
5. Duval A, Busson-Leconiat M, Berger R, Hamelin R. Assignment of the TCF-4 gene (TCF7L2) to human chromosome band 10q25.3. Cytogenet Cell Genet 2000;88:264-5.
6. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, et al. TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program. N Engl J Med 2006;355:241-50.
7. Ingelsson E, Langenberg C, Hivert MF, Prokopenko I, Lyssenko V, Dupuis J, et al. Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans. Diabetes 2010;59:1266-75.
8. Bhatti GK, Kaur S, Vijayvergiya R, Bhadada SK, Mastana SS, Singh B, et al. ENPP1 K121Q functional variant enhances susceptibility to insulin resistance and dyslipidemia with metabolic syndrome in Asian Indians. Int J Diabetes Metab 2018;21:8-15.
9. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
10. Dutra LA, Costa PG, Velasco LF, Amato AA, Barra GB. Allele-specific PCR assay to genotype SNP rs7903146 in TCF7L2 gene for rapid screening of diabetes susceptibility. Arq Bras Endocrinol Metabol 2008;52:1362-6.
11. Bhatti JS, Joshi A, Mastana S, Bansal D, Bhatti GK, Rai S, et al. Identification of the risk factors for the high prevalence of Type 2 diabetes and its complications in a Punjabi population: North indian diabetes study: A case-control study. Int J Diabetes Dev Ctries 2007;27:108-15.
12. Arafat M, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors: In multinational community. Int J Pharm Pharm Sci 2014;6:257-60.
13. Haghighatpanah M, Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, et al. Correlation of glycosylated hemoglobin levels with fasting and postprandial glucose in south Indian Type 2 diabetic patients. Int J Pharm Pharm Sci 2016;8:285-8.
14. Jyothi KU, Jayaraj M, Subburaj KS, Prasad KJ, Kumuda I, Lakshmi V, et al. Association of TCF7L2 gene polymorphisms with T2DM in the population of Hyderabad, India. PLoS One 2013;8:e60212.
15. Smith U. TCF7L2 and Type 2 diabetes we WNT to know. Diabetologia 2007;50:5-7.
16. Gougelet A, Torre C, Veber P, Sartor C, Bachelot L, Denechaud PD, et al. T-cell factor 4 and ?-catenin chromatin occupancies pattern zonal liver metabolism in mice. Hepatology 2014;59:2344-57.
17. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of Type 2 diabetes. Nat Genet 2006;38:320-3.
18. Bodhini D, Radha V, Dhar M, Narayani N, Mohan V. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with Type 2 diabetes mellitus in Asian Indians. Metabolism 2007;56:1174-8.
19. Chandak GR, Janipalli CS, Bhaskar S, Kulkarni SR, Mohankrishna P, Hattersley AT, et al. Common variants in the TCF7L2 gene are strongly associated with Type 2 diabetes mellitus in the Indian population. Diabetologia 2007;50:63-7.
20. Singh K, Agrawal NK, Gupta SK, Singh K. Association of variant rs7903146 (C/T) single nucleotide polymorphism of TCF7L2 gene with impairment in wound healing among North Indian Type 2 diabetes population: A case-control study. Int J Low Extrem Wounds 2013;12:310-5.
21. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, Rayner NW, et al. Association analysis of 6,736 U.K. Subjects provides replication and confirms TCF7L2 as a Type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006;55:2640-4.
22. Zhang C, Qi L, Hunter DJ, Meigs JB, Manson JE, van Dam RM, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of Type 2 diabetes in large cohorts of U.S. Women and men. Diabetes 2006;55:2645-8.
23. Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with Type 2 diabetes in a finnish sample. Diabetes 2006;55:2649-53.
24. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with Type 2 diabetes in the amish: Replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006;55:2654-9.
25. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with Type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006;55:2890-5.
26. Cauchi S, Meyre D, Dina C, Choquet H, Samson C, Gallina S, et al. Transcription factor TCF7L2 genetic study in the french population: Expression in human beta-cells and adipose tissue and strong association with Type 2 diabetes. Diabetes 2006;55:2903-8.
27. van Vliet-Ostaptchouk JV, Shiri-Sverdlov R, Zhernakova A, Strengman E, van Haeften TW, Hofker MH, et al. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to Type 2 diabetes in the dutch breda cohort. Diabetologia 2007;50:59-62.
28. Humphries SE, Gable D, Cooper JA, Ireland H, Stephens JW, Hurel SJ, et al. Common variants in the TCF7L2 gene and predisposition to Type 2 diabetes in UK European whites, Indian Asians and afro-caribbean men and women. J Mol Med (Berl) 2006;84:1005-14.
29. Marzi C, Huth C, Kolz M, Grallert H, Meisinger C, Wichmann HE, et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with Type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. Horm Metab Res 2007;39:46-52.
30. Horikoshi M, Hara K, Ito C, Nagai R, Froguel P, Kadowaki T, et al. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of Type 2 diabetes in the japanese population. Diabetologia 2007;50:747-51.
31. Tong Y, Lin Y, Zhang Y, Yang J, Zhang Y, Liu H, et al. Association between TCF7L2 gene polymorphisms and susceptibility to Type 2 diabetes mellitus: A large human genome epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009;10:15.
32. Song Y, Yeung E, Liu A, Vanderweele TJ, Chen L, Lu C, et al. Pancreatic beta-cell function and Type 2 diabetes risk: Quantify the causal effect using a mendelian randomization approach based on meta-analyses. Hum Mol Genet 2012;21:5010-8.
33. Wang J, Hu F, Feng T, Zhao J, Yin L, Li L, et al. Meta-analysis of associations between TCF7L2 polymorphisms and risk of Type 2 diabetes mellitus in the Chinese population. BMC Med Genet 2013;14:8.
34. Luo Y, Wang H, Han X, Ren Q, Wang F, Zhang X, et al. Meta-analysis of the association between SNPs in TCF7L2 and Type 2 diabetes in East Asian population. Diabetes Res Clin Pract 2009;85:139-46.
35. Gupta V, Khadgawat R, Ng HK, Walia GK, Kalla L, Rao VR, et al. Association of TCF7L2 and ADIPOQ with body mass index, waist-hip ratio, and systolic blood pressure in an endogamous ethnic group of India. Genet Test Mol Biomarkers 2012;16:948-51.
36. Mandour I, Darwish R, Fayez R, Naguib M, El-Sayegh S. TCF7L2 gene polymorphisms and susceptibility to Type 2 diabetes mellitus, a pilot study. Biomed Pharmacol J 2018;11:1043-9.
37. Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, et al. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome. J Nutr Biochem 2012;23:239-44.
38. Bodhini D, Gaal S, Shatwan I, Ramya K, Ellahi B, Surendran S, et al. Interaction between TCF7L2 polymorphism and dietary fat intake on high density lipoprotein cholesterol. PLoS One 2017;12:e0188382.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.